Polpharma Biologics SA has partnered up with Novartis subsidiary Sandoz AG to market a natalizumab...
Up To Date
Latest News
German pharma company Boehringer Ingelheim said the phase II trial for candidate drug BI456906 is expected to...
Results presented at European Society of Cardiology Congress 2019 demonstrate a new disease mechanism...
A US-EU research team has found that a class of compounds that promote tumour cell death can also limit...
Celgene will pay $75m upfront to get an option on three cancer programmes developed by Immatics...
Danish microbiology specialist Unibio International plc had completed a US$15m financing round led by West...